Critically, patients carrying TP53 missense mutations have a higher incidence of lymph node metastases than their TP53 gene deletion counterparts, suggesting that TP53 missense mutations possess gain-of-function mechanisms mediating cancer cell dissemination. Here, TP53 is linked to cancer.